Search - tctmd.com

Displaying 221 - 240 of 509

Sort: Relevancy | Date

News Daily News

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Michael O'Riordan

November 20, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

News Industry News

Concept Medical Inc. Raises $60mn For Investigational Device Exemption (IDE) For The World’s First Sirolimus-Coated Balloon

October 10, 2018

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

Shelley Wood

September 24, 2018

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

News Conference News TCT 2018

Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014

Yael L. Maxwell

September 21, 2018

News Daily News

PCI in Nonagenarians Rising as Focus Shifts to Frailty Over Age

Yael L. Maxwell

September 18, 2018

News Conference News ESC 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Todd Neale

August 28, 2018

$A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years$

News Daily News

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Yael L. Maxwell

August 10, 2018

News Daily News

CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL

Caitlin E. Cox

August 09, 2018

News Daily News

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Michael O'Riordan

July 19, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Daily News

Many Invasive Procedures, Including Cardiovascular, Up Risk of Infective Endocarditis

Caitlin E. Cox

June 11, 2018

News Daily News

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

Yael L. Maxwell

June 08, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Industry News

CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018

May 24, 2018

News Industry News

Positive Two-Year Data from MiStent® DESSOLVE III Trial Presented at EuroPCR

May 24, 2018

Advertisement

Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Concept Medical Inc. Raises $60mn For Investigational Device Exemption (IDE) For The World’s First Sirolimus-Coated Balloon

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Radial Access Doubled for Left Main PCI in the UK Between 2007 and 2014

PCI in Nonagenarians Rising as Focus Shifts to Frailty Over Age

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Many Invasive Procedures, Including Cardiovascular, Up Risk of Infective Endocarditis

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018

Positive Two-Year Data from MiStent® DESSOLVE III Trial Presented at EuroPCR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content